[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:becker-s-muscular-dystrophy":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":65,"states":66},"Becker's Muscular Dystrophy",9,8,[8,15,21,27,33,39,45,51,57],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05016908","Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy",[],"RECRUITING","2026-08-26T02:18:46.137046Z","2026-05-13T02:55:06.278359Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT01484678","Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy",[],"2026-08-26T02:18:52.966503Z","2026-05-13T02:55:06.074346Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07674758","Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials",[],"2026-08-26T02:18:44.395098Z","2026-07-05T03:45:20.436420Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT07609394","Duchenne Electronic Health Record Study",[],"2026-08-26T02:18:16.220328Z","2026-05-29T15:36:40.227967Z",{"nct_id":34,"title":35,"phases":36,"status":12,"updated_at":37,"content_modified":38},"NCT05019625","Biomarker Development for Muscular Dystrophies",[],"2026-08-26T02:15:36.077529Z","2026-05-13T02:55:06.278851Z",{"nct_id":40,"title":41,"phases":42,"status":12,"updated_at":43,"content_modified":44},"NCT02069756","The Duchenne Registry",[],"2026-08-26T02:15:24.145250Z","2026-05-13T02:55:06.081909Z",{"nct_id":46,"title":47,"phases":48,"status":12,"updated_at":49,"content_modified":50},"NCT00390104","Molecular Analysis of Patients With Neuromuscular Disease",[],"2026-08-26T02:15:50.539717Z","2026-05-13T02:55:06.035661Z",{"nct_id":52,"title":53,"phases":54,"status":12,"updated_at":55,"content_modified":56},"NCT07332013","Urinary Titin Biomarker in DMD",[],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:26.920539Z",{"nct_id":58,"title":59,"phases":60,"status":62,"updated_at":63,"content_modified":64},"NCT06066580","Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy",[61],"Phase 2","ENROLLING_BY_INVITATION","2026-08-26T02:16:47.762107Z","2026-06-16T05:54:08.096795Z",[],[67,71,74,77,81],{"state":68,"count":69,"slug":70},"Massachusetts",4,"massachusetts",{"state":72,"count":69,"slug":73},"North Carolina","north-carolina",{"state":75,"count":69,"slug":76},"Pennsylvania","pennsylvania",{"state":78,"count":79,"slug":80},"California",3,"california",{"state":82,"count":79,"slug":83},"District of Columbia","district-of-columbia"]